Metraipolis › archive › dc_dd669948a97f
Risk of hepatitis B virus reactivation in the treatment of HBsAg and HBV DNA double-negative lymphoma patients — Europe PMC PMID:40961165
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40961165
- DOI
- 10.1371/journal.pone.0332421
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T22:02:24.098Z
- SHA-256 of the archived text
51f801f446ffd0a22fd6da26b44c7c00b69590233fd5c492090473f59f20860a- Stable URL of this page
https://metraipolis.com/documento/dc_dd669948a97f
How to cite
Risk of hepatitis B virus reactivation in the treatment of HBsAg and HBV DNA double-negative lymphoma patients — Europe PMC PMID:40961165 — Europe PMC (en), https://europepmc.org/article/MED/40961165 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_dd669948a97f (Metraipolis archive dc_dd669948a97f, sha256 51f801f446ffd0a22fd6da26b44c7c00b69590233fd5c492090473f59f20860a)
BibTeX
@misc{dcdd669948a97f,
title = {Risk of hepatitis B virus reactivation in the treatment of HBsAg and HBV DNA double-negative lymphoma patients — Europe PMC PMID:40961165},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40961165},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_dd669948a97f; sha256 51f801f446ffd0a22fd6da26b44c7c00b69590233fd5c492090473f59f20860a},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40961165. Agents can read the archived copy with the MCP tool read_document.